Progression of coronary calcium scores: Harder gets the evidence

JACC: Cardiovascular Imaging

Volumn 5, Issue 4, 2012, Pages 465-466

  Shaw, Leslee J ^a   Chandrashekhar, Y ^b   Narula, Jagat ^c  

^a EMORY UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE COURSE; EDITORIAL; ETHNIC DIFFERENCE; HUMAN; METABOLIC SYNDROME X; PRIORITY JOURNAL; SCORING SYSTEM;

CALCINOSIS; CALCIUM; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X;

EID: 84859620633     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.03.002     Document Type: Editorial

References (10)

1. N.D. Wong, J.C. Nelson, T. Granston Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study J Am Coll Cardiol Img 5 2012 358 366
2. P. Raggi, L.J. Shaw, D.S. Berman, T.Q. Callister Prognostic value of coronary artery calcium screening in subjects with and without diabetes J Am Coll Cardiol 43 2004 1663 1669 (Pubitemid 38561350)
3. Y. Arad, K.J. Goodman, M. Roth, D. Newstein, A.D. Guerci Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study J Am Coll Cardiol 46 2005 158 165 (Pubitemid 40905145)
4. J.K. Min, F.Y. Lin, D.S. Gidseg Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal? J Am Coll Cardiol 55 2010 1110 1117
5. J.C. Kovacic, V. Fuster Vascular calcification, diabetes, and cardiovascular disease: connecting the dots J Am Coll Cardiol Img 5 2012 367 369
6. V.L. Roger, A.S. Go, D.M. Lloyd-Jones Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
7. J.W. McEvoy, M.J. Blaha, A.P. Defilippis Coronary artery calcium progression: an important clinical measurement? A review of published reports J Am Coll Cardiol 56 2010 1613 1622
8. A. Schmermund, S. Achenbach, T. Budde Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial Circulation 113 2006 427 437 (Pubitemid 43803205)
9. P.G. O'Malley A double take on serial measurement of coronary artery calcification Arch Intern Med 169 2009 2051 2052
10. Ridker P.M., Danielson E., Fonseca F.A. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 2008 359 2195-2207.